Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, et al.
Cancer Discovery (2022) Vol. 12, Iss. 12, pp. 2774-2799
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 554
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
Xiuting Liu, Graham D. Hogg, Chong Zuo, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1073-1090.e12
Open Access | Times Cited: 44
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer
Meirion Raymant, Yuliana Astuti, Laura Álvaro‐Espinosa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Ludovica Arpinati, Giulia Carradori, Ruth Scherz‐Shouval
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 676-693
Closed Access | Times Cited: 16
Hydrogen‐Bonded Organic Framework Nanoscintillators for X‐Ray‐Induced Photodynamic Therapy in Hepatocellular Carcinoma
Lihui Gu, Han Wu, Xu Li, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 2
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Dallas B. Flies, Solomon Langermann, Christina Jensen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D. DeMarco, Christina F. Lusi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 762
Open Access | Times Cited: 13
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Baoyuan Zhang, Ning Li, Jiaming Gao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications
Qian Zhang, Zi-Yi An, Wen G. Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115390-115390
Open Access | Times Cited: 20
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
A Self‐Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic Cancer
Ying Liu, Babatunde O. Okesola, David Osuna de la Peña, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 7
Functional heterogeneity of fibroblasts in primary tumors and metastases
Priscilla S.W. Cheng, Marta Zaccaria, Giulia Biffi
Trends in cancer (2024)
Open Access | Times Cited: 7
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 6
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment
Kris Raaijmakers, Gosse J. Adema, Johan Bussink, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 768-768
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top